Best Practices for Management of Mental Health in Women: Focusing on Mood Disorders Throughout The Lifespan
Released On
July 31, 2023
Expires On
October 31, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Primary Care, Psychiatry
Topic(s)
Depression, Major Depression, Mental Health
This activity is supported by an educational grant from Mylan Inc., a Viatris Company.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is designed to meet the educational needs of Psychiatrists, primary care physicians, and other health care providers
Program Overview
As women experience mood symptoms throughout their reproductive years and during menopausal transitions, they often have regular contact with health care providers, providing an opportunity for treatment intervention during this complex period of a woman’s life and involving them in their own treatment program so that they can be as remitted as possible and lead a full life. It is important that clinicians know how to differentiate diagnoses and understand which treatment options are available and how to discuss them with women. In this video Drs Marlene Freeman, MD, Professor of Psychiatry at Harvard Medical School, and Kathryn Abel, MA, MBBS, FRCP, PhD, Professor of Psychological Medicine, University of Manchester, present 3 cases that address menstrual cycle-related mood disorders, MDD and other psychiatric disorders across the reproductive lifespan, and menopausal transition and mood symptoms and provide guideline recommendations and best practices for the management of these issues. With many treatment options available to women, from antidepressants to hormone therapy to new treatment options including neurosteroids, clinicians can help women make the best decisions for themselves and create patient-centered, individualized, evidence-based treatment plans to optimize outcomes across their lifespans.
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Appraise the influence of the reproductive stage on mood disorders and comorbid psychiatric conditions in women.
- Assess factors involved in the diagnoses of mood disorders in women and the differential diagnoses and common comorbidities.
- Summarize evidence-based approaches for diagnosing and treating mood disorders in women.
Faculty
Kathryn Abel, MA, MBBS, FRCP, FRCPsych, PhD
Professor of Psychological Medicine
University of Manchester
Manchester, UK
Marlene P. Freeman, MD
Professor of Psychiatry
Harvard Medical School
Cambridge, MA
Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Financial Relationships
The CME Institute adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME). Any individuals in a position to control the content of a continuing education activity, including faculty, content developers, reviewers, staff, and others, are required to disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
The CME Institute has mitigated all relevant conflicts of interest prior to the commencement of the activity. None of the individuals involved in the content have relevant financial relationships with ineligible companies except the following:
Dr. Abel has received consulting fees from Flo Health; has served on the advisory board for Karolinska Institute (ended); has received royalties from Cambridge University Press and The Royal College of Psychiatrists; and is a stock shareholder in Google and Amgen.
Dr. Freeman as an employee of Massachusetts General Hospital, working with the MGH Clinical Trials Network and Institute, has had research funding from multiple pharmaceutical companies and NIMH. MGH National Pregnancy Registry has been sponsored by Alkermes, Inc. (2016-Present), Eisai, Inc. (2022-Present), Johnson & Johnson/Janssen Pharmaceuticals, Inc (2019-Present), Otsuka America Pharmaceutical, Inc. (2008-Present), Sage Therapeutics (2019-Present), Sunovion Pharmaceuticals, Inc. (2011-Present), Supernus Pharmaceuticals (2021-Present), and Teva Pharmaceutical Industries Ltd. (2018-Present). Past Sponsors include Forest/Actavis/Allergan (2016-2018), AstraZeneca Pharmaceuticals (2009-2014), AuroMedics Pharma LLC (2021-2022), Aurobindo Pharma (2020-2022), Ortho-McNeil-Janssen Pharmaceuticals, Inc (2009-2014), and Pfizer, Inc. (2009-2011); has received advisory boards or consulting fees from Data Safety Committees and Independent Data Safety and Monitoring Committees from Janssen (Johnson& Johnson), Novartis, Neurocrine, Eliem, Sage, Brainify, Everly Health, Tibi Health, Relmada, Beckley Psytech, and Brii Biotech; received honoraria for speaking/teaching from WebMD, Medscape, Pri-Med, Postpartum Support International; and has received royalties from The Massachusetts General Hospital Female Reproductive Lifecycle and Hormones Questionnaire.
None of the other planners, reviewers, and CME Institute staff for this educational activity have relevant financial relationships with ineligible companies to disclose. All relevant financial relationships have been mitigated.
Instructions for Receiving Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The CME Institute of Physicians Postgraduate Press, Inc., requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions please contact: [email protected] .